Back
Interparfums 10K Form
Buy
63
IPAR
Interparfums
Last Price:
137.47
Seasonality Move:
9.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | IPAR/Interparfums Quarterly |
2023-11-09 | 10Q | IPAR/Interparfums Quarterly |
2023-11-07 | 10Q | IPAR/Interparfums Quarterly |
2023-08-08 | 10Q | IPAR/Interparfums Quarterly |
2023-05-08 | 10Q | IPAR/Interparfums Quarterly |
2022-11-09 | 10Q | IPAR/Interparfums Quarterly |
Receive IPAR News And Ratings
See the #1 stock for the next 7 days that we like better than IPAR
IPAR Financial Statistics
Sales & Book Value
Annual Sales: | $1.32B |
---|---|
Cash Flow: | $75.1M |
Price / Cash Flow: | 54.9 |
Annual Sales: | $24.30 |
Price / Book: | 5.66 |
Profitability
EPS (TTM): | 4.67000 |
---|---|
Net Income (TTM): | $150.55M |
Gross Margin: | $839.08M |
Return on Equity: | 16.5% |
Return on Assets: | 10.82% |
Interparfums Earnings Forecast
Key Interparfums Financial Ratios
- The Gross Profit Margin over the past 37 years for IPAR is 63.68%.
- The Selling, General & Administrative Expenses for IPAR have been equal to 44.60% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 7.37% of Operating Income.
- The Net Earning history of IPAR is 11.59% of Total Revenues.
- Per Share Earnings over the last 37 years have been positive in 26 years.
Interparfums Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Personal Care Products |
Sector: | Consumer Staples |
Current Symbol: | IPAR |
CUSIP: | 458334 |
Website: | interparfumsinc.com |
Debt
Debt-to-Equity Ratio: | 0.24 |
---|---|
Current Ratio: | 2.82 |
Quick Ratio: | 1.52 |
Price-to-Earnings
Trailing P/E Ratio: | 28.94 |
---|---|
Forward P/E Ratio: | 25.7 |
IPAR Technical Analysis vs Fundamental Analysis
Buy
63
Interparfums (IPAR)
is a Buy
Is Interparfums a Buy or a Sell?
-
Interparfums stock is rated a Buy
The current Interparfums [IPAR] share price is $137.48. The Score for IPAR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.